Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study

Table 1

Baseline characteristics of study populations.

Characteristic	European American	African American
	(n = 7350)	(n = 2814)
Age, years	54.3±5.7	53.2±5.8
Male, %	46.2	37.1
SBP, mmHg	118.2±16.5	127.3±19.5
DBP, mmHg	71.8±9.7	79.4±11.4
Hypertension, %	26.1	54.0
Antihypertensive Use, %	24.8	42.8
BMI, kg/m^2	27.0±4.8	29.8±6.2
Diabetes, %^†	8.0	17.7
Current Smoking, %	23.4	28.2

Data presented as mean±standard deviation or percentage.
SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index.
Defined as SBP ≥ 140 mmHg, a DBP ≥ 90 mmHg, or antihypertensive medication usage.
^†Defined as a fasting glucose ≥ 126 mg/dL, non-fasting glucose ≥ 200 mg/dL, or use of antidiabetes mellitus medication.